Researchers based in the state recognised as the skin cancer capital of the world have developed revolutionary technology that has the potential to improve the detection and diagnosis of this disease.
28 May 2014A Member of
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B